Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal

Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal

Abstract Background HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and prophylactic lamivudine (LMV) treatment is suggested to prevent this phenomenon. However, the duration of LMV treatment in HSCT patients is not fully defined and the tim...

Full description

Bibliographic Details
Main Authors: C. Cerva, G. Maffongelli, V. Svicher, R. Salpini, L. Colagrossi, A. Battisti, B. Mariotti, R. Cerretti, L. Cudillo, L. Sarmati
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Infectious Diseases
Subjects:
HBV reactivation
Hbv DNA
Prophylaxis
Hepatitis B
Hematopoietic stem cell transplantation
Online Access:http://link.springer.com/article/10.1186/s12879-017-2672-6

Internet

http://link.springer.com/article/10.1186/s12879-017-2672-6

Similar Items